Messages of Hope for Atypical Parkinsonism

Messages of Hope for Atypical Parkinsonism

Welcome to our message board dedicated to the journey of atypical Parkinsonism. Here, individuals, caregivers, health professionals, and all those connected can share their experiences, both challenging and uplifting. Post your stories, ask questions, or offer words of encouragement. This space is for support, learning, and fostering a community where every message can inspire, comfort, and connect us all.


Message Board ⤵️

Note: All comments and messages on this board are public and can be viewed by anyone who visits this page.

Back to blog

3 comments

Yesterday, our new physiotherapist visited for the first time since taking over Ronwyn’s care. She came to the house to observe the lifting techniques I use to help Ronwyn move between seats and the bed. She also noticed that I have a sash, which I occasionally use to lift Ronwyn from the floor when she has slid down.

Ronwyn has significant strength in her hands and arms. Our current method relies on her gripping the lifter and using her upper body strength to stand up. I believe this is beneficial in helping her maintain her strength.

While the sash can be useful, it is cumbersome to put on and impractical for everyday use. The physiotherapist wants me to use it all the time, but based on my experience, that’s not a realistic solution. Being young, she lacks the hands-on experience and practical knowledge I have, leading her to make assumptions about the best approach. However, experience has shown that her suggested method is not always the most effective. I’ve found this to be a common trend among many healthcare professionals, who often rely on textbook advice rather than practical solutions.

Peter Firmin

In the face of adversity, I choose hope—always.

Tim Brown

Together, we are stronger. Each message here is a beacon of hope, reminding us that we are not alone in this journey with atypical Parkinsonism. Let’s keep the light of support shining.

Laura Louizos

Leave a public comment:

  • Remembering Rev. Jesse Jackson: A Warrior’s Fight Against PSP

    Remembering Rev. Jesse Jackson: A Warrior’s Fig...

    We at CCF for PSP Awareness are deeply saddened by the passing of Rev. Jesse Jackson, civil rights pioneer, at age 84 on February 17, 2026, in Chicago.  His death...

    Remembering Rev. Jesse Jackson: A Warrior’s Fig...

    We at CCF for PSP Awareness are deeply saddened by the passing of Rev. Jesse Jackson, civil rights pioneer, at age 84 on February 17, 2026, in Chicago.  His death...

  • 🥯 Bagel Fundraiser

    🥯 Bagel Fundraiser

    JOIN THE COLEEN CUNNINGHAM FOUNDATION 🥯 Bagel Fundraiser FOR THE BENEFIT OF THOSE WITHAtypical Parkinson Diseases NOVEMBER 2ND • 11-1 PM AT THE ROCKVILLE JCC IN PARTNERSHIP WITH BETHESDA BAGELS

    1 comment

    🥯 Bagel Fundraiser

    JOIN THE COLEEN CUNNINGHAM FOUNDATION 🥯 Bagel Fundraiser FOR THE BENEFIT OF THOSE WITHAtypical Parkinson Diseases NOVEMBER 2ND • 11-1 PM AT THE ROCKVILLE JCC IN PARTNERSHIP WITH BETHESDA BAGELS

    1 comment
  • HOPE by Bhavna

    HOPE by Bhavna

    Remember the first timerobins sang in your garden,their delicate bodies pulsing with song,their hearts daring to rise, like yours.How the moon spilled its silver over your window,and your mother said,...

    HOPE by Bhavna

    Remember the first timerobins sang in your garden,their delicate bodies pulsing with song,their hearts daring to rise, like yours.How the moon spilled its silver over your window,and your mother said,...

  • Active Neurodegenerative Disease Clinical Trials (PSP, MSA, DLB, CBS, Parkinsonian Syndromes)

    Active Neurodegenerative Disease Clinical Trial...

    Progressive Supranuclear Palsy (PSP) Trials ClinicalTrials.gov ID: NCT06355531 – PROSPERPurpose: To evaluate whether FNP-223 slows disease progression in PSP, using the PSP Rating Scale (PSPRS) over 52 weeks. The trial also...

    2 comments

    Active Neurodegenerative Disease Clinical Trial...

    Progressive Supranuclear Palsy (PSP) Trials ClinicalTrials.gov ID: NCT06355531 – PROSPERPurpose: To evaluate whether FNP-223 slows disease progression in PSP, using the PSP Rating Scale (PSPRS) over 52 weeks. The trial also...

    2 comments
1 of 4